Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age

Aim:To determine the dermal progression of neonatal jaundice in newborns under 35 weeks of gestational age and those risk factors which affect dermal progression.Materials and Methods:We prospectively enrolled eighty-eight preterm newborns under 35 weeks of gestational age in neonatol intensive care unit of Dokuz Eylül University Hospital. It was a cross-sectional analytic case study. We measured capillary and transcutaneous bilirubin levels. Multiple sites of TcB measurement were performed.Results:We observed that there is no significant difference between capillary and transcutaneous bilirubin measurements on preterm newborns under 35 weeks of gestational age (pearson’s rho >75 and p0.05).Conclusion:Transcutaneous bilirubin measurements can be used for neonatal jaundice of newborns under 35 weeks of gestational age. However, we need further studies for comprehensive descriptions of preterm newborns’ jaundice progression.